7 Legal & ethical considerations
There are many legal and ethical aspects to responsible preclinical research. This chapter lists important resources, in particular relating to the situation in Switzerland. We recommend consulting the relevant guidelines early, ideally in the planning phase of a project. Also, whenever possible, we recommend following any standard for transparency agreements and lab procedures. We suggest considering such frameworks as resources enshrining expert and societal consensus on responsible research.
7.1 Legislation
In Switzerland, the «dignity of living beings» has been enshrined in the Federal Constitution (Art. 120 para. 2) since 1992, and the «dignity of animals» in the Animal Welfare Act (Art. 1 in conjunction with Art. 3 let. a) since 2008. For more details, consult the regulatory framework summary by Swissuniversities.
Laws and ordinances
- Animal Welfare Act (AniWA; 455)
- Protects animal dignity and ensures animal welfare.
- Ordinance on Animal Protection (TSchV/OPAn; 455.1)
- Defines rules on animal handling, use, and housing.
- Regulates how interventions are performed on animals (e.g., authorized and forbidden procedures, analgesia, housing infrastructure requirements).
- Animal Experimentation Ordinance (AEO; 455.163)
- Defines rules on laboratory animal breeding.
- Regulates genetically modified animals.
- Specifies requirements for laboratory animal breeding announcements and animal experimentation.
- Animal Welfare Training Ordinance (AWTO; 455.109.1)
- Defines the basic education needed for persons working with animals.
- Establishes content and minimal duration of education and training courses.
- Specifies requisite continuing education for persons working with animals.
- Ordinance on Electronic Management of Animal Experiments (VerTi-V/O-SIGEXPA; 455.61)
- Regulates the operation of the management information system for animal experimentation.
- Covers reports, basic training, and continuing education certificates.
- Containment Ordinance (ContainO 814.912)
- Regulates “the handling of organisms, in particular genetically modified, pathogenic or alien organisms, in contained systems.”
7.3 Swiss Transparency Agreement on Animal Research (STAAR)
Swissuniversities has set up the STAAR Commission to improve communication and transparency regarding the use of animals in research. The signatory organizations agree to the following commitments):
- We will be clear about how and why we use or support the use of animals in research,
- We will enhance our communication with the public and the media about our involvement with research using animals,
- We will be proactive in providing opportunities for the public to find out about our involvement with research using animals,
- We will report on progress annually and share our experiences
The specific objectives of STAAR are defined each year (see STAAR standards).
7.4 Ethics
- Ethics Committee for Animal Experimentation
- Developed principles and guidelines: Ethical principles and guidelines for experiments on animals.
- Created the guidance: Weighing of interests for proposed animal experiments. Guidance for applicants.
- Developed principles and guidelines: Ethical principles and guidelines for experiments on animals.
- Dignity of the Animal Study Group (FSVO)
- Devised a model procedure to ensure that weighing of interests is carried out correctly and uniformly.
7.5 Good Laboratory Practices (GLP)
The goal of GLPs is to ensure quality of the process and conditions under which studies are planned, performed, monitored, recorded, archived and reported.
Animal tests carried out in accordance with GLP for chemicals, therapeutic products (human and animal), plant protection products and biocidal products in Switzerland are internationally recognised. This means that the tests do not have to be repeated for each country, thus unnecessary animal tests can be avoided (principle of reduction).
- There is a Swiss Federal ordinance on GLPs: 813.112.1 Ordinance of 18 May 2005 on Good Laboratory Practice (OGLP)
Other relevant GLP authorities are:
Organisation for Economic Co-operation and Development (OECD) (see OECD Series on Principles of GLP and compliance monitoring)
U.S. Food and Drug Administration (US-FDA). See GLP for nonclinical laboratory studies)
European Medicines Agency (EMEA)